RSV Prevention: Vaccines and Antibody Treatments for Babies
The short answer
RSV prevention for babies has advanced significantly with two key options: nirsevimab (Beyfortus), a monoclonal antibody given to babies to provide direct protection, and a maternal RSV vaccine (Abrysvo) given during pregnancy to pass protective antibodies to the baby. The AAP and CDC recommend that all infants entering their first RSV season receive nirsevimab. Previously, only high-risk premature infants received RSV protection through palivizumab (Synagis).
This is one of the most common questions parents ask. Searching for answers means you care.
By Age
What to expect by age
0-6 months
Young infants are at highest risk for severe RSV illness. Nirsevimab (Beyfortus) is recommended for all infants under 8 months entering their first RSV season. It is given as a single injection and provides approximately 5 months of protection. If the mother received the Abrysvo vaccine during pregnancy (given at 32-36 weeks gestation), the baby may not need nirsevimab, though your pediatrician will help decide based on timing. These are not traditional vaccines but monoclonal antibodies that give immediate passive protection.
6-12 months
Babies 8-19 months old who are at increased risk for severe RSV (due to prematurity, chronic lung disease, congenital heart disease, or immunocompromise) may receive nirsevimab before their second RSV season. For most healthy babies over 8 months, additional RSV prevention is not routinely needed as their immune systems are more mature. Continue standard precautions during RSV season: frequent handwashing, avoiding sick contacts, and keeping your baby away from crowded indoor spaces when possible.
12-36 months
Most toddlers do not need RSV-specific prevention unless they have underlying health conditions that put them at high risk. Children with chronic lung disease, significant congenital heart disease, or severe immunodeficiency may qualify for continued protection. Talk to your pediatrician about whether your toddler needs additional RSV prevention. By this age, most children have already been infected with RSV at least once and have developed some natural immunity, though reinfection is possible.
What Should You Do?
When to take action
- Your baby received nirsevimab and is healthy - mild injection site reactions like redness or soreness are normal.
- Your baby did not receive RSV prevention and is healthy with no underlying conditions during their second RSV season.
- You received the Abrysvo vaccine during pregnancy and your pediatrician confirms your baby has adequate protection.
- You are unsure whether your baby should receive nirsevimab and want to discuss eligibility.
- You are pregnant and want to discuss whether the maternal RSV vaccine is right for you.
- Your baby has a chronic health condition and you want to understand RSV prevention options.
- Your baby develops signs of RSV illness regardless of immunization status: fast breathing, wheezing, difficulty feeding, or chest retractions.
- Your baby has an allergic reaction after receiving nirsevimab: hives, facial swelling, difficulty breathing.
- Your premature or high-risk infant is exposed to RSV and has not received any preventive treatment.
Sources
Related Resources
Trust your instincts. If something feels wrong, reach out to your pediatrician.
Worrying about your baby means you care. That is a good thing.
Related Medical Concerns
RSV in Babies: What to Know
RSV (respiratory syncytial virus) is a common virus that affects nearly all children by age 2. Most babies have mild cold-like symptoms, but some, especially young infants and those with underlying conditions, can develop breathing difficulties. Watch for fast breathing, flaring nostrils, or visible chest pulling - these are signs to seek medical care.
Catching Up on Delayed Vaccinations
If your baby has fallen behind on vaccinations for any reason, catch-up schedules are available and your pediatrician can create a plan to get them up to date. It is never too late to catch up. The CDC provides detailed catch-up immunization schedules. Delayed vaccines do not need to be restarted - you pick up where you left off. Getting caught up quickly is important because your child is unprotected against preventable diseases during the gap.
Vaccine Hesitancy: Navigating Social Media Misinformation
Childhood vaccines are among the most thoroughly studied medical interventions in history and have been proven safe and effective by decades of research involving millions of children. The original study claiming a link between vaccines and autism was fraudulently fabricated and has been thoroughly debunked by hundreds of subsequent studies. Social media algorithms often amplify anti-vaccine content because it generates emotional engagement. Your pediatrician is the best resource for evidence-based answers to vaccine questions.
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.